Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Pfizer
Pfizer
Institut d'Investigació Biomèdica de Bellvitge
Fundacion Clinic per a la Recerca Biomédica
Istanbul University
Rwanda Biomedical Centre
GlaxoSmithKline
Hospital Clinic of Barcelona
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Xiamen Innovax Biotech Co., Ltd
Region Stockholm
Sunnybrook Health Sciences Centre
Peking Union Medical College Hospital
Medstar Health Research Institute
University of Pittsburgh
GlaxoSmithKline
Loyola University
GlaxoSmithKline
CHU de Reims
Merck Sharp & Dohme LLC
Medical University of Lublin
Shandong Cancer Hospital and Institute
University of Kansas Medical Center
Air Force Military Medical University, China
Asan Medical Center
Boston Medical Center
Fox Chase Cancer Center
Duke University
National Cancer Institute (NCI)
London School of Hygiene and Tropical Medicine
Columbia University
University of Copenhagen